Flow Diversion Aneurysm Treatment Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (FDS, Intrasaccular flow disruption devices), By End User (Hospitals, Specialty clinics), By Region & Competition, 2020-2030F

Description

The global Flow Diversion Aneurysm Treatment Market was valued at USD 1.98 billion in 2024 and is projected to experience significant growth during the forecast period, with a compound annual growth rate (CAGR) of 7.72% through 2030. This market is evolving rapidly within the neurointerventional sector, driven by the urgent need to address cerebral aneurysms, a potentially life-threatening condition. The market is characterized by the use of flow diversion devices, a minimally invasive treatment designed to reroute blood flow away from aneurysms, aiding in their occlusion and reducing the risk of rupture. Continuous advancements in flow diversion technologies and neuroimaging techniques are broadening treatment options and enhancing patient outcomes. The rising incidence of cerebral aneurysms, often linked to aging and other risk factors, is further propelling demand for effective treatment solutions. Compared to traditional surgical approaches, flow diversion procedures are less invasive, leading to shorter recovery times and reduced hospital stays.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.98 Billion
Market Size 2030	USD 3.07 Billion
CAGR 2025-2030	7.72%
Fastest Growing Segment	FDS
Largest Market	North America

Key Market Drivers

The Flow Diversion Aneurysm Treatment Market is experiencing notable growth, primarily driven by the increasing adoption of minimally invasive treatment options. This trend reflects a shift in the management of cerebral aneurysms, prioritizing less invasive procedures over traditional open surgeries. Several factors contributing to this shift include:

Minimally invasive procedures typically require smaller incisions or access points, resulting in reduced tissue damage, less pain, and faster recovery times compared to open surgery. This approach is highly appealing to both patients and healthcare providers.

Flow diversion treatments yield excellent patient outcomes, with lower complication rates and reduced risks of infection or bleeding, which boosts patient satisfaction and enhances the reputation of these procedures.

Advances in medical devices and imaging technologies have made minimally invasive treatments more precise and effective. Real-time imaging guidance plays a critical role in increasing the accuracy of flow diversion procedures.

Key Market Challenges

Despite the promising growth of the market, high procedural costs remain a significant challenge. These costs encompass various aspects of treatment, including the price of flow diversion devices, hospital fees, physician charges, and post-procedure care. Contributing factors to the elevated costs include:

Flow diversion devices, while highly effective, can be expensive, and the cost of these specialized devices forms a substantial part of the overall treatment expenses.

Performing flow diversion procedures requires specialized training, which incurs additional costs for education and certification.

The complexity of pre-operative assessments, extended hospital stays, and follow-up care also increases overall healthcare costs.

While technological advancements in devices and medical tools may lead to better outcomes, they can also result in higher upfront costs.

Reimbursement rates for flow diversion procedures in some healthcare systems may not fully cover the costs, creating financial constraints for hospitals and healthcare providers. High procedural costs can also limit patient access to these advanced treatments.

Addressing these challenges requires a multi-pronged approach, including optimizing the cost-effectiveness of flow diversion devices, improving reimbursement strategies, and expanding access to specialized care. Overcoming these barriers is essential to ensuring equitable patient access to life-saving treatments and ensuring the sustainability of healthcare systems.

Key Market Trends

A growing adoption of flow diversion techniques is a prominent trend in the market, with an increasing preference for flow diversion procedures as the primary method for managing cerebral aneurysms. Key factors contributing to this trend include:

Flow diversion procedures are less invasive compared to traditional open surgeries, attracting patients seeking treatments that offer quicker recovery times, reduced pain, and smaller incisions.

Flow diversion techniques have proven to be highly effective in treating complex aneurysms, such as wide-necked and fusiform aneurysms, that were previously difficult to manage. This effectiveness has led to greater trust and acceptance among both physicians and patients.

Ongoing innovations in flow diversion devices, including improvements in design, materials, and delivery systems, have enhanced their safety and efficacy, further promoting adoption.

Patients undergoing flow diversion procedures often experience positive outcomes, including lower rates of aneurysm recurrence and fewer complications, contributing to higher patient satisfaction and confidence in the treatment.

An increasing number of neurointerventionalists are being trained in flow diversion techniques, expanding the availability of these procedures in medical centers globally. The growing body of clinical evidence supporting the effectiveness of flow diversion in preventing aneurysm rupture is further driving its adoption.

Key Market Players

Acandis GmbH
BALT Group
Cardinal Health Inc
Endologix LLC
Evasc Medical Systems Corp
Imperative Care Inc
InspireMD Inc
Johnson & Johnson
Lepu Medical Technology Beijing Co. Ltd
Medtronic Plc

Market Segmentation

This report segments the global Flow Diversion Aneurysm Treatment Market into the following categories:

By Product:

Flow Diverter Stents (FDS)
Intrasaccular Flow Disruption Devices

By End User:

Hospitals
Specialty Clinics

By Region:

North America (United States, Canada, Mexico)
Europe (France, United Kingdom, Italy, Germany, Spain)
Asia-Pacific (China, India, Japan, Australia, South Korea)
South America (Brazil, Argentina, Colombia)
Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

The report provides a detailed analysis of the major players in the Flow Diversion Aneurysm Treatment Market, including their strategies, market share, and key business developments.

Available Customizations

TechSci Research offers customizations for this global Flow Diversion Aneurysm Treatment Market report according to specific company needs. Customization options include:

Detailed analysis and profiling of additional market players (up to five).

Product Code: 18929

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flow Diversion Aneurysm Treatment Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (FDS, Intrasaccular flow disruption devices)
- 5.2.2. By End User (Hospitals, Specialty clinics)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Flow Diversion Aneurysm Treatment Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By End User
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Flow Diversion Aneurysm Treatment Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By End user
- 6.3.2. Canada Flow Diversion Aneurysm Treatment Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By End user
- 6.3.3. Mexico Flow Diversion Aneurysm Treatment Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By End user

7. Europe Flow Diversion Aneurysm Treatment Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By End User
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Flow Diversion Aneurysm Treatment Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By End user
- 7.3.2. United Kingdom Flow Diversion Aneurysm Treatment Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By End user
- 7.3.3. Italy Flow Diversion Aneurysm Treatment Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By End user
- 7.3.4. France Flow Diversion Aneurysm Treatment Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By End user
- 7.3.5. Spain Flow Diversion Aneurysm Treatment Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By End user

8. Asia-Pacific Flow Diversion Aneurysm Treatment Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By End User
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Flow Diversion Aneurysm Treatment Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By End user
- 8.3.2. India Flow Diversion Aneurysm Treatment Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By End user
- 8.3.3. Japan Flow Diversion Aneurysm Treatment Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By End user
- 8.3.4. South Korea Flow Diversion Aneurysm Treatment Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By End user
- 8.3.5. Australia Flow Diversion Aneurysm Treatment Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By End user

9. South America Flow Diversion Aneurysm Treatment Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By End User
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Flow Diversion Aneurysm Treatment Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By End user
- 9.3.2. Argentina Flow Diversion Aneurysm Treatment Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By End user
- 9.3.3. Colombia Flow Diversion Aneurysm Treatment Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By End user

10. Middle East and Africa Flow Diversion Aneurysm Treatment Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By End User
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Flow Diversion Aneurysm Treatment Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By End user
- 10.3.2. Saudi Arabia Flow Diversion Aneurysm Treatment Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By End user
- 10.3.3. UAE Flow Diversion Aneurysm Treatment Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By End user

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisition

13. Global Flow Diversion Aneurysm Treatment Market: SWOT Analysis

14. Competitive Landscape

14.1. Acandis GmbH
- 14.1.1. Business Overview
- 14.1.2. Treatment Offerings
- 14.1.3. Recent Developments
- 14.1.4. Key Personnel
- 14.1.5. SWOT Analysis
14.2. BALT Group
14.3. Cardinal Health Inc
14.4. Endologix LLC
14.5. Evasc Medical Systems Corp
14.6. Imperative Care Inc
14.7. InspireMD Inc
14.8. Johnson and Johnson
14.9. Lepu Medical Technology Beijing Co. Ltd
14.10.Medtronic Plc